Al's Comment:

 They announced an increase of 3-4 months in median overall survival. That sounds like nothing but for DIPG it is significant. It is very rare for a DIPG trial to show any benefit.  This could be the start of major progress against DIPG as part of a combination of therapies.

Posted on: 06/08/2021

Y-mAbs Announces Update on Omburtamab for DIPG


Click HERE to return to brain tumor news headlines.